
Please visit answersincme.com/CKX860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Prithviraj Bose, MD. In this activity, an expert in hematology discusses the role of current and emerging treatment options for patients living with advanced systemic mastocytosis. Upon completion of this activity, participants should be better able to: Identify prognostic features of advanced systemic mastocytosis (AdvSM) that guide diagnosis and care planning; Describe current and emerging treatment options for patients with AdvSM; and Evaluate patient- and disease-related strategies that inform treatment selection in AdvSM.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

From Surgery to Systemic Therapy: A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy

It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria

Transforming Outcomes for Patients With Chronic Spontaneous Urticaria: A New Era of Targeted Therapy

From Evidence to Action: Expert Dialogues on the Evolving Role of Immunotherapy in Basal Cell Carcinoma
Free AI-powered recaps of CME in Minutes: Education in Dermatology and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.